Therefore, additional markers, including Axin 2 abundance and/or TCF4 nuclear localisation, will need to be tested to be able to make a clear statement on whether the loss of SFRP1 is associated with canonical Wnt-signalling in CMT or not. This evidence concerns the gene AXIN2 and Charcot-Marie-Tooth disease.